Human immunodeficiency virus type 1 impairs sumoylation.
Journal
Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
21
04
2021
revised:
07
02
2022
accepted:
08
02
2022
entrez:
19
2
2022
pubmed:
20
2
2022
medline:
26
4
2022
Statut:
epublish
Résumé
During infection, the human immunodeficiency virus type 1 (HIV-1) manipulates host cell mechanisms to its advantage, thereby controlling its replication or latency, and evading immune responses. Sumoylation is an essential post-translational modification that controls vital cellular activities including proliferation, stemness, or anti-viral immunity. SUMO peptides oppose pathogen replication and mediate interferon-dependent anti-viral activities. In turn, several viruses and bacteria attack sumoylation to disarm host immune responses. Here, we show that HIV-1 impairs cellular sumoylation and targets the host SUMO E1-activating enzyme. HIV-1 expression in cultured HEK293 cells or in CD4
Identifiants
pubmed: 35181598
pii: 5/6/e202101103
doi: 10.26508/lsa.202101103
pmc: PMC8860096
pii:
doi:
Substances chimiques
UBA2 protein, human
0
Ubiquitin-Activating Enzymes
EC 6.2.1.45
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022 Mete et al.
Références
J Immunol Res. 2015;2015:541984
pubmed: 26636107
Nat Rev Microbiol. 2013 Jun;11(6):400-11
pubmed: 23624814
Mol Immunol. 2005 Feb;42(2):145-52
pubmed: 15488604
Nat Rev Mol Cell Biol. 2003 Sep;4(9):690-9
pubmed: 14506472
Trends Biochem Sci. 2012 Jan;37(1):23-31
pubmed: 22018829
Front Microbiol. 2018 Sep 11;9:2131
pubmed: 30254620
J Virol. 2003 Jun;77(12):7101-5
pubmed: 12768029
Biol Pharm Bull. 1999 Oct;22(10):1122-6
pubmed: 10549869
N Engl J Med. 2011 May 19;364(20):1943-54
pubmed: 21591946
J Virol. 2012 Jan;86(2):642-54
pubmed: 22072786
J Virol. 2015 Sep;89(17):8932-44
pubmed: 26085151
Mol Cell. 2004 Nov 19;16(4):549-61
pubmed: 15546615
Immunol Rev. 2019 Nov;292(1):149-163
pubmed: 31883174
Pathog Immun. 2016 Spring;1(1):107-116
pubmed: 27500281
Nat Rev Cancer. 2017 Mar;17(3):184-197
pubmed: 28134258
Nat Rev Mol Cell Biol. 2007 Dec;8(12):947-56
pubmed: 18000527
Oncogene. 1999 Jan 28;18(4):935-41
pubmed: 10023669
BMC Genomics. 2013 Nov 23;14:824
pubmed: 24267727
Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71
pubmed: 21102611
Cell. 2010 Nov 24;143(5):694-702
pubmed: 21111231
Sci Signal. 2009 May 26;2(72):ra24
pubmed: 19471022
PLoS Pathog. 2012 Jan;8(1):e1002484
pubmed: 22291592
Nat Immunol. 2018 Sep;19(9):923-931
pubmed: 30104634
Cell Host Microbe. 2014 Jun 11;15(6):717-728
pubmed: 24922574
PLoS One. 2015 Apr 07;10(4):e0122585
pubmed: 25848798
Proc Natl Acad Sci U S A. 1984 Oct;81(19):6134-8
pubmed: 6091137
Virulence. 2010 Nov-Dec;1(6):532-4
pubmed: 21178495
Nat Med. 2003 Jul;9(7):847-52
pubmed: 12835704
Cytokine Growth Factor Rev. 2016 Jun;29:3-16
pubmed: 27157810
Nat Commun. 2014 Jun 19;5:4187
pubmed: 24942926
EC Microbiol. 2016;3(6):597-604
pubmed: 28580453
J Infect Dis. 1992 Dec;166(6):1236-44
pubmed: 1331248
Nat Rev Microbiol. 2007 Apr;5(4):253-63
pubmed: 17325726
Oxid Med Cell Longev. 2016;2016:8910396
pubmed: 27829986
Immunol Rev. 2001 Aug;182:5-17
pubmed: 11722620
Mol Microbiol. 2004 Mar;51(5):1375-87
pubmed: 14982631
Front Microbiol. 2015 Jan 29;6:21
pubmed: 25688236
J Biol Chem. 2000 Mar 3;275(9):6252-8
pubmed: 10692421
J Gen Virol. 1995 Jun;76 ( Pt 6):1509-14
pubmed: 7782780
Subcell Biochem. 2010;54:195-214
pubmed: 21222284
Mol Cell Proteomics. 2008 Jan;7(1):132-44
pubmed: 17938407
Nature. 2010 Apr 22;464(7292):1192-5
pubmed: 20414307
Science. 2008 Feb 15;319(5865):921-6
pubmed: 18187620
Mol Cell. 2005 Apr 1;18(1):1-12
pubmed: 15808504
Cell Rep. 2015 Nov 17;13(7):1467-1480
pubmed: 26549460
PLoS Pathog. 2015 Jul 22;11(7):e1005059
pubmed: 26200910
Cell. 2000 Oct 13;103(2):283-94
pubmed: 11057901
FEBS J. 2020 Aug;287(15):3110-3140
pubmed: 32255256
Nature. 1995 Jan 5;373(6509):78-81
pubmed: 7800043
PLoS Pathog. 2011 Sep;7(9):e1002245
pubmed: 21949651
J Cell Biol. 2014 Mar 17;204(6):931-45
pubmed: 24637324
Cell Mol Life Sci. 2007 Aug;64(15):1979-96
pubmed: 17530464
Virus Res. 2011 Nov;161(2):101-14
pubmed: 21871504
Nat Struct Mol Biol. 2014 Oct;21(10):927-36
pubmed: 25218447
PLoS Pathog. 2017 Apr 17;13(4):e1006338
pubmed: 28414785
AIDS Rev. 2018 Jan-Mar;20(1):3-13
pubmed: 29369304
Dev Cell. 2005 Dec;9(6):769-79
pubmed: 16326389
Curr Issues Mol Biol. 2020;35:159-194
pubmed: 31422939
J Autoimmun. 2017 Nov;84:21-28
pubmed: 28919255
J Biol Chem. 2001 Sep 21;276(38):35368-74
pubmed: 11451954
Biochem Soc Trans. 2018 Jun 19;46(3):691-698
pubmed: 29784645
Int J Biochem Cell Biol. 1999 Dec;31(12):1443-52
pubmed: 10641798
Trends Cell Biol. 2018 Nov;28(11):926-940
pubmed: 30107971
Cell. 2008 Oct 3;135(1):49-60
pubmed: 18854154
Cytokine Growth Factor Rev. 2013 Dec;24(6):559-70
pubmed: 23953672
Viruses. 2017 Oct 31;9(11):
pubmed: 29088112
Prog Mol Biol Transl Sci. 2012;109:75-112
pubmed: 22727420
PLoS Pathog. 2015 Jul 21;11(7):e1005051
pubmed: 26197391
J Virol. 2002 Jan;76(2):841-50
pubmed: 11752173
Viruses. 2013 Jul 16;5(7):1787-801
pubmed: 23863879
J Biol Chem. 2011 Jun 10;286(23):21013-22
pubmed: 21454548
Biochem J. 2010 May 13;428(2):133-45
pubmed: 20462400
Front Immunol. 2019 Sep 25;10:2268
pubmed: 31681261
mBio. 2020 Sep 29;11(5):
pubmed: 32994335
FEBS Lett. 1998 May 29;428(3):235-40
pubmed: 9654140